Binding of galectin-3 by low molecular weight pectin

  • US 9,427,449 B2
  • Filed: 06/06/2011
  • Issued: 08/30/2016
  • Est. Priority Date: 08/26/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a mammal which benefits from a reduction in available circulating galectin-3, comprising the steps of:

  • a) Selecting a mammal in need of at least one of inhibition or reduction of inflammation, andb) Administering to said mammal an amount of modified citrus pectin of molecular weight of 3,000-13,000 Daltons, in an amount of 10-750 mg/kg/day, for a period of time sufficient such that said mammal exhibits a reduction in active galectin-3 levels in said mammal and thereby inhibit in said mammal said inflammation or thereby reduce it.

View all claims

    Thank you for your feedback